KMT2A and gastric cancer: In the study, the prognostic value of KMT2A was demonstrated to be associated with poor outcome of gastric cancer patients and was recognized as a regulator of stemness in gastric cancer through regulating Wnt/β-catenin-induced expression of stemness-related genes.